Velakast Tablets
+ Free ShippingWe are manfacturer,trader & supplier of Velakast Tablets. Velakast tablet contains Sofosbuvir 400mg & Velpatasvir 100mg is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. Velakast is the FDA approved product, which is used in chronic HCV condition. Velakast should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections. is the FDA approved product, which is used in chronic HCV condition. Velakast should be used in genotype I, II, III, IV, V or VI associated hepatitis C viral infections.
DOSAGE BEFORE THE TREATMENT
Examine the patients thoroughly, before initiating the treatment with HCV anti-viral agents. Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs. Velakast tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of Velpanat; The usual recommended dose of Velakast is, one tablet should be administered orally as a single dose. Velakast tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir